University College Dublin

The Agency Expands Global Reach with New Office in Jamaica

Retrieved on: 
Wednesday, February 21, 2024
Cayman Islands, Professional, Land Rover, Culture, Chartered Surveyor, University, History, WSJ, Partner, Turks and Caicos Islands, Social media, Rookie of the Year, Bachelor, Ethics, Marketing, The New York Times, Eye, Law school, Swanepoel, Management, Financial Times, Royal Institution, Human resource management, TCI, Brand management, University College Dublin, Dow Jones & Company, BMW, Mercedes-Benz, Industrial and organizational psychology, Coldwell, University of Cape Town, Brighton College, Unit, Partner (business rank), Real estate

LOS ANGELES, Feb. 21, 2024 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new office in Jamaica. The new locale, which will be known as The Agency Jamaica, is the firm's first office in the country of Jamaica, joining the brokerage's growing network of offices in the U.S., Canada, Mexico, Central America, the Caribbean, and Europe. The office will be led by accomplished industry veterans Matthew 'Taff' Stevenson, Rebecca Stevenson, Sean O'Neill, and Ian Hurdle who will all serve as Managing Partners, as well as David Thwaites, who will serve as Managing Broker. The Agency has several offices throughout the Caribbean including in Turks & Caicos, The Bahamas, The Cayman Islands, and the Dominican Republic.

Key Points: 
  • LOS ANGELES, Feb. 21, 2024 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new office in Jamaica.
  • Taff Stevenson is a dynamic force in the real estate world, currently leading the charge as Managing Partner at The Agency Jamaica.
  • Now, as Managing Partner of The Agency Jamaica, Rebecca is not just a real estate expert with ten years of experience.
  • The Agency's office in Jamaica will be located at Unit 15A, 9-11 Phoenix Avenue Kingston JM KGN 10.

Helmsley Charitable Trust Awards Over $12 Million to Projects Aimed at Helping People With Type 1 Diabetes Safely Incorporate Exercise Into Their Daily Lives

Retrieved on: 
Tuesday, February 13, 2024
Technology, Research, Sports, Diabetes, Managed Care, General Health, Data Analytics, General Sports, Pharmaceutical, Medical Devices, Health Technology, Fitness & Nutrition, Clinical Trials, Professional Services, Artificial Intelligence, Biotechnology, Philanthropy, Software, Health, Foundation, Science, University, OpenAPS, Algorithm, University of Pennsylvania, University College Dublin, Doctor of Philosophy, Multimedia, Education, FDA, Himawari (satellites), Quality of life, AID, Charitable trust, Menstruation, Exercise, CCRA, MBA, Risk, Stanford University, University of Trento, Safety, RFP, Helmsley, Hypoglycemia, Insulin, MPH, York University, Knowledge, Clinical trial, Trial of the century

Today, The Leona M. and Harry B. Helmsley Charitable Trust announces seven new grants to support research aimed at helping people with type 1 diabetes (T1D) more safely incorporate exercise into their lives.

Key Points: 
  • Today, The Leona M. and Harry B. Helmsley Charitable Trust announces seven new grants to support research aimed at helping people with type 1 diabetes (T1D) more safely incorporate exercise into their lives.
  • More research and solutions are urgently needed to ease the burden of exercise with T1D management.
  • The data sets are publicly available through Vivli, a data-sharing platform that hosts information on a variety of health conditions.
  • The study will provide practical advice and a potentially cost-effective solution for people with T1D engaging in exercise.

Cairn Homes Plc: Appointment of Chief Financial Officer

Retrieved on: 
Tuesday, February 13, 2024
CFO, University College Dublin, Euronext Dublin, IPO, Partner, Business, AGM, Business administration, Trinity College Dublin, Annual, Greater Dublin Area, Trinity College

Richard Ball, an experienced real estate professional, will join Cairn as Chief Financial Officer

Key Points: 
  • Richard Ball, an experienced real estate professional, will join Cairn as Chief Financial Officer
    Dublin/London, 13 February 2024: Cairn Homes plc (“Cairn” or “the Company”) (Euronext Dublin: C5H / LSE: CRN), a leading Irish homebuilding company, today announces, following a comprehensive recruitment process, the appointment of Richard Ball as Chief Financial Officer (“CFO”), succeeding Shane Doherty.
  • Prior to that, he served as Chief Investment Officer at Hibernia REIT plc, an Irish commercial real estate company, for a period of five years from its IPO.
  • John Reynolds, Chairman of Cairn, said: "We are delighted to be appointing a high calibre candidate in Richard Ball as CFO.
  • A new Cairn home is expertly designed, with a focus on creating shared spaces and environments where communities thrive.

Aquila Air Capital Adds Eoin Connaughton to Commercial Analysis and Pricing Team

Retrieved on: 
Monday, January 29, 2024
Professional Services, Air, Logistics, Supply Chain Management, Aerospace, Transport, Manufacturing, Finance, Origination (telephony), Associate, Faculty, Knowledge, Connaughton, Commercial, Standard Chartered, Business analyst, SMBC, Aircraft, Faculty of Actuaries, SMBC Aviation Capital, Data analysis, Law society, Chow Tai Fook, Marketing, AVP, University College Dublin, Growth, Risk management

Against the backdrop of this year’s Airline Economics Growth Frontiers Dublin conference, Aquila Air Capital (“Aquila”), a leading lessor focused on end-of-life solutions, announced the addition of a new member to its Commercial Analysis and Pricing team, Eoin Connaughton as AVP, Commercial Analysis and Pricing.

Key Points: 
  • Against the backdrop of this year’s Airline Economics Growth Frontiers Dublin conference, Aquila Air Capital (“Aquila”), a leading lessor focused on end-of-life solutions, announced the addition of a new member to its Commercial Analysis and Pricing team, Eoin Connaughton as AVP, Commercial Analysis and Pricing.
  • Connaughton will be based out of the company’s Irish office, focusing on the analysis, structuring, and pricing of transactions for various aircraft and engine types in collaboration with the Commercial and Origination teams.
  • Connaughton joins Aquila from SMBC Aviation Capital (“SMBC”), where most recently he served as VP, Commercial Analysis, working closely with the Marketing and Trading teams to ensure all transactions were appropriately structured, accurately priced, and completed in a timely fashion.
  • I am excited to be able to bring my extensive knowledge and skillset to assist in the expansion of the current leasing and trading platform,” commented Eoin Connaughton as Aquila Air Capital’s AVP, Commercial Analysis and Pricing.

Tibidabo Scientific Industries Appoints Paul McEvoy as Group Chief Commercial Officer

Retrieved on: 
Monday, January 8, 2024
Growth, Marketing, Paul's walk, University College Dublin, Management

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Tibidabo Scientific Industries Ltd ("Tibidabo Scientific") is delighted to announce the appointment of Paul McEvoy as Group Chief Commercial Officer.

Key Points: 
  • DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Tibidabo Scientific Industries Ltd ("Tibidabo Scientific") is delighted to announce the appointment of Paul McEvoy as Group Chief Commercial Officer.
  • In this pivotal role, Paul will spearhead the design and implementation of unified sales and marketing strategies across all Tibidabo Scientific companies.
  • "We are thrilled to welcome Paul to Tibidabo Scientific," said Viktoriya Baytser, Group President.
  • We are confident that his strategic vision, dedication and leadership will be pivotal in driving the commercial success of Tibidabo Scientific."

Moa Technology hires for further growth with expansion of its leadership team – announcing appointment of CFO and US-based CBO to support advancement of next-generation herbicides

Retrieved on: 
Monday, November 20, 2023
Triangle Park (Quezon City), Corporation, Silence Therapeutics, Research, Research Triangle Park, Bachelor of Science, Business development, Therapy, CFO, Flagship Pioneering, University College Dublin, Biology, Bayer, GSK, Farmer, Health, Mergers and acquisitions, MBA, University, Growth, Doctor of Philosophy, Bioherbicide, Control, Newcastle University, Herbicide, CBO, Management, Pharmaceutical industry, Telescopic sight, Agriculture, Biochemistry, Syngenta, Apostolos, Moa

He has extensive experience of helping biotech companies raise funding, both through equity funding and industry collaborations.

Key Points: 
  • He has extensive experience of helping biotech companies raise funding, both through equity funding and industry collaborations.
  • His appointment also reflects Moa’s use of cutting-edge biotechnology processes to identify, understand and develop next-generation herbicides with game-changing speed and accuracy.
  • Without effective herbicides, farmers can lose up to 40% of their crop yield as a result of weed growth.
  • Dr. Virginia Corless, Chief Executive Officer of Moa Technology, says:
    “Moa is tackling a major crisis that threatens farmers’ livelihoods and global food security.

Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP - Head of Europe

Retrieved on: 
Tuesday, November 14, 2023
Ophthalmology, Senior, Therapy, Royal college, Bevacizumab, MAA, Outlook, University College Dublin, EMA, ADHD, FDA, Marketing, Partnership, AMD, Doctor of Philosophy, Market access, Retina, Pharmaceutical industry, Chemistry, Science

ISELIN, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced the appointment of Jedd Comiskey as Senior VP – Head of Europe.

Key Points: 
  • ISELIN, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced the appointment of Jedd Comiskey as Senior VP – Head of Europe.
  • Mr. Comiskey has a successful track record in the planning, organization and execution of product launches.
  • Over the course of his career, he has demonstrated innovative, solution-focused results, navigating the highly complex European pharmaceutical landscape.
  • “We believe in the potential of ONS-5010 to address the global need for an approved bevacizumab that meets ophthalmic standards for the treatment of wet AMD.

Taoglas Shoots for the Stars in Ireland's First Satellite

Retrieved on: 
Monday, December 4, 2023
Aerospace, IOT (Internet of Things), Manufacturing, Satellite, Technology, CubeSat, European Space Agency, Internet of things, Engineering, RF, GPS, Shock, University College Dublin, Space research, Student, Education, Multimedia, GNSS, Orbit, SpaceX, SpaceX launch vehicles, UCD, Communications satellite, Surveying

Taoglas' GPS/GALILEO patch antenna was chosen for its lightweight and low-volume characteristics while ensuring high gain and wide bandwidth.

Key Points: 
  • Taoglas' GPS/GALILEO patch antenna was chosen for its lightweight and low-volume characteristics while ensuring high gain and wide bandwidth.
  • "We are immensely proud that Ireland's first satellite, EIRSAT-1, will have an Irish satellite antenna and cable solution on board.
  • Taoglas provided the ideal solution with their direct solder mount GNSS antenna, demonstrating the innovation and precision necessary for this pioneering mission."
  • You can watch Taoglas’ video about their involvement in the EIRSAT-1 mission here: https://youtu.be/fr3ZtYtXT0g

B. Riley Launches US-Based Executive Search Practice

Retrieved on: 
Wednesday, November 29, 2023
Interim management, Senior, Heidrick & Struggles, University College Dublin, James B. Riley, University college, Marketing, Master of Science, CPG, University, Health care, Economic history of Mexico, Business, Retail, Economics

LOS ANGELES, Nov. 29, 2023 /PRNewswire/ -- B. Riley Advisory Services, a leading provider of business advisory, appraisal and consulting services and subsidiary of B. Riley Financial (Nasdaq: RILY), is pleased to announce the addition of Alistair Ross as a Senior Vice President, based in California.

Key Points: 
  • Ross is an experienced executive search consultant and has been brought on to lead the Los Angeles office, the first expansion into the U.S. for the firm's Executive Search & Interim Management practice that was established through the addition of Farber Group in February 2023.
  • Prior to joining B. Riley, Ross led the U.S. expansion of a global boutique executive search firm catering to the private equity industry.
  • "We are pleased to welcome Alistair and his talents to our firm as we strategically scale our Executive Search & Interim Management practice in the U.S.," said Ian Ratner, Co-CEO of B. Riley Advisory Services.
  • Ian Brenner, leader of the firm's Executive Search & Interim Management practice, added, "The launching of this new location is an exciting expansion of B. Riley's Executive Search capabilities, which to date, have been focused on the Canadian market.

GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions

Retrieved on: 
Thursday, October 5, 2023
Consultant, Injury, HIV disease progression rates, Frontiers, Biomarker, NKT, Doctor of Philosophy, Osteopontin, Natural killer T cell, School, Inflammation, Manuscript, IPF, Alcoholic hepatitis, Saint Vincent, Disease, NASH, GRI, Fibroblast, Teaching hospital, IL-6, Idiopathic pulmonary fibrosis, Rheumatoid arthritis, Movement, Liver function tests, St. Vincent's University Hospital, Oxygen, LA, Lupus nephritis, Lupus, Medical school, Associate, Multiple sclerosis, University College Dublin, Fibrosis, Tissue, NK, Macrophage, Human, Cytokine, Chemokine, Patient, Neutrophil, Vaccine, Pharmaceutical industry, Medicine

LA JOLLA, CA, Oct. 05, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the publication of an article that reviews data in both experimental models and in humans that suggest a key role of type 1 invariant NKT (iNKT) cell activation in the progression of inflammatory cascades leading to recruitment of neutrophils and activation of the inflammasome, macrophages, fibroblasts, and, ultimately, fibrosis. The manuscript titled, “Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis,” has been published in Frontiers in Immunology.1

Key Points: 
  • iNKT are pro-inflammatory effector T cells that accumulate in many models of chronic fibrotic diseases such as idiopathic pulmonary fibrosis (IPF), lupus nephritis and NASH.
  • I am encouraged by the emerging experimental evidence that iNKT cells play an important role in chronic inflammation and fibrosis.
  • iNKT cells are involved in the regulation of all three, type 1, type 2 and type 3 cytokine associated fibrotic pathways.
  • GRI Bio’s lead program, GRI-0621 is a small molecule RAR-βɣ dual agonist that inhibits the activity of human type 1, iNKT cells.